Naoki Ishizuka

Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211

Motoko Yamaguchi, Kensei Tobinai, Masahiko Oguchi et al. · Journal of Clinical Oncology · 2009 · 338 citations

Medicine, Oncology, Radiation Oncology +14

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 309 citations

Medicine, Cardiology, Internal Medicine +13

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or Older With Atherosclerotic Risk Factors

Yasuo Ikeda, Kazuyuki Shimada, Tamio Teramoto et al. · JAMA · 2014 · 305 citations

Medicine, Cardiology, Pharmacotherapy +17

Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101)

Ryosuke Tsuchiya, Kenji Suzuki, Yukito Ichinose et al. · Journal of Thoracic and Cardiovascular Surgery · 2005 · 157 citations · Full text

Medicine, Oncology, Surgery +13

Assertive case management versus enhanced usual care for people with mental health problems who had attempted suicide and were admitted to hospital emergency departments in Japan (ACTION-J): a multicentre, randomised controlled trial

Chiaki Kawanishi, Tohru Aruga, Naoki Ishizuka et al. · The Lancet Psychiatry · 2014 · 107 citations

Social Sciences, Emergency Medicine, Psychiatry +9